About this episode

Dr Andree Bates discusses why simply stating 'we're doing AI' is insufficient for board-level discussions and outlines the importance of a strategic approach to AI investment.

In this solo episode of AI For Pharma Growth, Dr Andree Bates explains why “we’re doing AI” is not a credible board answer, and why activity, pilots and steering committees are not the same as strategy. Dr Andree breaks down two common answers leadership teams give when asked about AI strategy. The episode explores why crowdsourced use cases often become “use case copying” rather than genuine internal innovation. A pain point may be real, and a pilot may work, but that does not mean it is one of the highest-value AI opportunities for the organisation. Without financial modelling, business-unit submissions are only inputs, not prioritisation. Dr Andree also outlines four structural conditions that explain why AI investment often fails to realise value: the value prioritisation gap, the decision rights gap, the data ownership conflict, and incentive misalignment. These issues are connected, and if they are diagnosed in the wrong order, the strategy usually fails at the next layer. The core message is clear: boards do not need a list of AI activity. They need a strategy they can govern, with clear priorities, financial assumptions, sequencing, ownership and metrics that can be…

People in this episode

Host: Dr Andree Bates

Topics covered

• AI strategy
• board governance
• value prioritization
• innovation
• data ownership
• decision rights

Keywords

• AI
• strategy
• innovation
• value prioritization
• data ownership
• decision rights
• business units
• use cases

More episodes of AI For Pharma Growth

• E234: The contrarian case for physics over data: can deterministic, training-free models beat ML in lead optimization? · September 8, 2026 · 44 min
• E233: The Diagnostic Room: The AI Capability Problem Pharma Hasn't Named · September 1, 2026 · 43 min
• E232: The Early Readout: Upgrading the Interim Analysis to Catch Futility and Success Years Sooner · August 25, 2026 · 28 min
• E231: The Diagnostic Room: You didn't have an AI problem. You had a capability problem. · August 18, 2026 · 37 min
• E230: The Last Untouched Dataset · August 11, 2026 · 24 min
• E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 · August 4, 2026 · 33 min

Explore listener stats, chart rankings, contacts and more on the AI For Pharma Growth podcast page.